Home
Scholarly Works
In vivo purging with rituxan prior to stem cell...
Conference

In vivo purging with rituxan prior to stem cell collection is associated with persistant molecular evidence of T(14;18) that often disappears post transplant in patients with follicular lymphoma.

Authors

Buckstein RJ; Imrie K; Spaner D; Bordeleau L; Iakhnina E; Pennell N; Coovadia A; Reis M; Hewitt K; Richardson P

Volume

94

Pagination

pp. 355B-355B

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 15, 1999

Conference proceedings

BLOOD

Issue

10

ISSN

0006-4971

Contact the Experts team